Loading patent…
AssigneeSouth Australian Health and Medical Research Institute Limited
InventorsTimothy John Sargeant, Julien Michel Bensalem
Estimating the term…
The present disclosure relates to relates to methods and products for assessing lysosomal system flux. In addition, the present disclosure also provides systems for assessing lysosomal system flux, and methods of identifying markers indicative of lysosomal system flux. In certain embodiments, the present disclosure provides a method of assessing lysosomal system flux in a subject. The method comprises determining the level of a lysosomal system marker in a sample of whole blood from the subject, the level of the lysosomal system marker being determined based on the level of the marker following treatment of the whole blood with an inhibitor of lysosomal system function.
A method of assessing lysosomal system flux in a subject, the method comprising determining the level of a lysosomal system marker in a sample of whole blood from the subject, the level of the lysosomal system marker being determined based on the level of the marker following treatment of the whole blood with an inhibitor of lysosomal system function.
(canceled)
A system for assessing lysosomal system flux in a subject, the system comprising:
A method of identifying a marker present in blood indicative of lysosomal system flux in a subject, the method comprising:
Dependencies are inferred from the claim text.